Earlier this month, Brookfield, under its Brookfield Wealth division, announced that it was entering the UK’s pension risk transfer (PRT) market, having gone through the approval process carried out by the Prudential Regulation Authority and the Financial Conduct Authority.
Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive.
Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.
The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.
“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.
Post a comment
Related Posts
New Data Shows the Extent to Which American Seniors Are Missing Out by Lapsing or Surrendering their Life Insurance Policy
Life settlement industry group the Life Insurance Settlement Association (LISA) has recently published the results…
Buy-Ins To Buy-Outs Appear Stalled As Deal Complexity, Administration Resources Pose Obstacles
A succession of high-activity years for defined benefit (DB) pension scheme bulk purchase annuity (BPA)…
Is Servicing an Overlooked Source of Life Settlement Alpha?
Life settlement asset managers have plenty to consider as they construct a diversified portfolio. Not…
UK Life Insurers to Benefit from Robust Bulk Annuity Market in 2025
UK life insurers are poised to continue benefitting from strong bulk annuity volumes in 2025…
